Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fungi have enormous potential for new antibiotics

20.04.2017

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from nature's own resources. The findings - which could prove very useful in the battle against antibiotic resistance - were recently published in the journal, Nature Microbiology.

Antibiotics have saved millions of lives since they were discovered in the 1940s. But recently we've had to learn a new term: antibiotic resistance. More and more bacteria are developing their own protection against antibiotics, thereby becoming resistant to treatment. This will lead to simple infections becoming lethal once again. Our need for new antibiotics is urgent.


While Penicillia are already industrially used in the production of antibiotics, other pharmaceuticals, industrial enzymes and in the manufacturing of food products, new research reveals that their potential for production of novel antibiotics is far from exhausted. Penicillia are naturally found in temperate climates growing on organic matter, including soil, plant material, dung and food products. The isolation of novel bioactive compounds from these species might encompass a source of new antibiotics to fight infectious microorganisms.

Credit: Jens Christian Nielsen

The first antibiotic to be mass-produced was penicillin, derived from Penicillium fungi. In their quest for new antibiotics, Chalmers researchers sequenced the genomes of nine different types of Penicillium species. And the findings are amazing:

"We found that the fungi have enormous, previously untapped, potential for the production of new antibiotics and other bioactive compounds, such as cancer medicines," says Jens Christian Nielsen, a PhD student at the Department of Biology and Biological Engineering.

He works in a research team led by another Chalmers researcher with almost the same name: Professor Jens Nielsen.

In the study, recently published in the journal, Nature Microbiology, the research group scanned the genomes of 24 different kinds of fungi to find genes responsible for the production of various bioactive compounds, like antibiotics. More than 1000 pathways were discovered, showing immense potential for fungi to produce a large variety of natural and bioactive chemicals that could be used as pharmaceuticals.

In about 90 cases, the researchers were able to predict the chemical products of the pathways. As evidence of this, they followed the production of the antibiotic, yanuthone, and identified new fungi able to produce the compound, but also that some species could produce a new version of the drug.

All in all, the study shows vast potential for fungi, not only in producing new antibiotics but also in enabling more efficient production of existing ones - and maybe also more effective versions of the existing ones.

"It's important to find new antibiotics in order to give physicians a broad palette of antibiotics, existing ones as well as new ones, to use in treatment. This will make it harder for bacteria to develop resistance," explains Jens Christian Nielsen.

"Previous efforts to find new antibiotics have mainly focused on bacteria. Fungi have been hard to study - we know very little of what they can do - but we do know that they develop bioactive substances naturally, as a way to protect themselves and survive in a competitive environment. This made it logical to apply our research tools to fungi."

Researchers now have various paths to follow. One way of moving forward could be to look further at the production of the new yanuthone compound. The Chalmers researchers have also drawn up a map that makes it possible to compare hundreds of genes in the continuous evaluation of bioactive products with potent drugs in sight.

How long it would take to launch new antibiotics on the market is impossible to say.

"Governments need to act. The pharmaceutical industry doesn't want to spend money on new antibiotics, it's not lucrative. This is why our governments have to step in and, for instance, support clinical studies. Their support would make it easier to reach the market, especially for smaller companies. This could fuel production," says Jens Christian Nielsen.

Johanna Wilde | EurekAlert!

Further reports about: Penicillium antibiotic antibiotics bacteria bioactive bioactive compounds fungi

More articles from Health and Medicine:

nachricht Fast-tracking T cell therapies with immune-mimicking biomaterials
16.01.2018 | Wyss Institute for Biologically Inspired Engineering at Harvard

nachricht Dengue takes low and slow approach to replication
12.01.2018 | Duke University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Novel 3-D printing technique yields high-performance composites

16.01.2018 | Materials Sciences

New application for acoustics helps estimate marine life populations

16.01.2018 | Life Sciences

Fast-tracking T cell therapies with immune-mimicking biomaterials

16.01.2018 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>